Lai Wang, Global Head of R&D at BeiGene, Ltd. (BGNE), sold 1,604 shares at $331.15 ($531K) on 2021-06-18, disclosed to the SEC on 2021-06-21.
Open-market sale of $531k BGNE by Global Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $331.15 | 802 | $266K | 50.0% |
| 2 | $331.15 | 802 | $266K | 50.0% |
| Total | $331.15 avg | 1,604 | $531K | 100% |
| Filing → |
| ONC | SELL | 2026-06-15 | $197K | — | Filing → |
| ONC | SELL | 2026-06-10 | $368K | — | Filing → |
| ONC | SELL | 2025-09-11 | $1.8M | — | Filing → |